Screener
Perrigo Company PRGO Specialty Care — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Perrigo Company in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Perrigo Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:44 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001585364-26-000145
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Total Self Care | $576.6 | $598.6 | $1,119.9 | $1,212.8 |
| Specialty Care | ||||
| Skin Health | $161.8 | $170.3 | $313.7 | $319.9 |
| Women's Health | 64.8 | 62.7 | 119.9 | 112.3 |
| Total Specialty Care | $226.6 | $233.1 | $433.6 | $432.2 |
| Infant Formula | $100.9 | $82.0 | $190.6 | $169.8 |
| All Other(1) | $118.6 | $142.7 | $247.8 | $285.4 |
| Total net sales | $1,022.8 | $1,056.3 | $1,992.0 | $2,100.2 |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Perrigo Company's specialty care — net sales?
- Perrigo Company (PRGO) reported specialty care — net sales of $226.6M in Q2 2026.
- What does specialty care — net sales mean?
- Represents the total revenue generated from the sale of products within the Specialty Care business segment. This metric reflects the market demand and commercial success of the segment's specialized pharmaceutical or healthcare offerings. It is a primary indicator of the segment's top-line growth and contribution to the overall corporate revenue stream.
Ask your AI about Perrigo Company's specialty care — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude